Works matching IS 00071048 AND DT 2018 AND VI 180 AND IP 2

Results: 24
    1

    Erratum.

    Published in:
    2018
    Publication type:
    Correction Notice
    2
    3
    4

    A single‐institution retrospective cohort study of first‐line R‐EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 2, p. 259, doi. 10.1111/bjh.15035
    By:
    • Rogers, Kerry A.;
    • Huang, Ying;
    • Ruppert, Amy S.;
    • Salem, Galena;
    • Stephens, Deborah M.;
    • Heerema, Nyla A.;
    • Andritsos, Leslie A.;
    • Awan, Farrukh T.;
    • Byrd, John C.;
    • Flynn, Joseph M.;
    • Maddocks, Kami J.;
    • Jones, Jeffrey A.
    Publication type:
    Article
    5

    Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 2, p. 246, doi. 10.1111/bjh.15033
    By:
    • Fujii, Shiro;
    • Nakamura, Shingen;
    • Oda, Asuka;
    • Miki, Hirokazu;
    • Tenshin, Hirofumi;
    • Teramachi, Jumpei;
    • Hiasa, Masahiro;
    • Bat‐Erdene, Ariunzaya;
    • Maeda, Yusaku;
    • Oura, Masahiro;
    • Takahashi, Mamiko;
    • Iwasa, Masami;
    • Endo, Itsuro;
    • Yoshida, Sumiko;
    • Aihara, Ken‐ichi;
    • Kurahashi, Kiyoe;
    • Harada, Takeshi;
    • Kagawa, Kumiko;
    • Nakao, Michiyasu;
    • Sano, Shigeki
    Publication type:
    Article
    6
    7
    8

    Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide <italic>versus</italic> investigator's choice in relapsed or refractory mantle cell lymphoma.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 2, p. 224, doi. 10.1111/bjh.15025
    By:
    • Arcaini, Luca;
    • Lamy, Thierry;
    • Walewski, Jan;
    • Belada, David;
    • Mayer, Jiri;
    • Radford, John;
    • Jurczak, Wojciech;
    • Morschhauser, Franck;
    • Alexeeva, Julia;
    • Rule, Simon;
    • Cabeçadas, José;
    • Campo, Elias;
    • Pileri, Stefano A.;
    • Biyukov, Tsvetan;
    • Patturajan, Meera;
    • Casadebaig Bravo, Marie‐Laure;
    • Trnĕný, Marek;
    • the SPRINT Trial Investigators
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Issue Information.

    Published in:
    British Journal of Haematology, 2018, v. 180, n. 2, p. 167, doi. 10.1111/bjh.14926
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.

    Published in:
    2018
    By:
    • Ghesquières, Hervé;
    • Larrabee, Beth R.;
    • Casasnovas, Olivier;
    • Maurer, Matthew J.;
    • McKay, James D.;
    • Ansell, Stephen M.;
    • Montgomery, Dorothy;
    • Asmann, Yan W.;
    • Farrell, Katrina;
    • Verney, Aurélie;
    • Slager, Susan L.;
    • Allmer, Cristine;
    • Perrot, Aurore;
    • Delarue, Richard;
    • Habermann, Thomas M.;
    • Dupuis, Jehan;
    • Link, Brian K.;
    • Canioni, Danielle;
    • Dogan, Ahmet;
    • Cozen, Wendy
    Publication type:
    Abstract